NeoGenomics, Inc.
NEO
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormalā¦ read more
Healthcare
Diagnostics & Research
20 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$6.24
Price+0.48%
$0.03
1Y
Price
Market Cap
$158.955m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-1.4%
EBITDA Margin-11.3%
Net Profit Margin+0.5%
Free Cash Flow MarginRevenue
$689.189m
+6.2%
1y CAGR+9.2%
3y CAGR+9.1%
5y CAGREarnings
-$104.038m
+10.7%
1y CAGR-526.1%
3y CAGR-469.6%
5y CAGREPS
-$4.05
+11.4%
1y CAGR-502.0%
3y CAGR-445.3%
5y CAGRBook Value
$0.00
$1.394b
Assets$439.790m
Liabilities$411.763m
DebtDebt to Assets
29.5%
-113.4x
Debt to EBITDAFree Cash Flow
-$19.172m
+3.2%
1y CAGR+21.6%
3y CAGR-41.0%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company